- Current report filing (8-K)
December 09 2010 - 10:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
December 9,
2010
CANTEL MEDICAL CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-31337
|
|
22-1760285
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Identification
|
of incorporation)
|
|
File Number)
|
|
Number)
|
150 Clove Road, Little Falls, New Jersey
|
|
07424
|
Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(973) 890-7220
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 2.02
Results of
Operations and Financial Condition
On
December 9, 2010, the Registrant issued a press release announcing its
results of operations for the quarter ended October 31, 2010 (Registrants
first quarter of fiscal year 2011). A
copy of the press release is included with this Report as Exhibit 99.1.
Item 9.01
Financial Statements,
Pro-Forma Financial Information and Exhibits
(d) Exhibit 99.1 Press release of Registrant dated December 9¸
2010.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
CANTEL
MEDICAL CORP.
|
|
|
|
|
|
By:
|
/s/
Andrew A. Krakauer
|
|
|
Andrew
A. Krakauer
|
|
|
President
and CEO
|
|
|
Dated: December 9,
2010
|
|
3
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024